Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease, characterised by a relapsing-remitting pattern of inflammatory activity, with each relapse contributing to irreversible end-organ damage with detrimental effects on patients’ course, adding up to morbidity burden and shortening lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Alvaro, Enman, Yvonne, Parodis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869695/
https://www.ncbi.nlm.nih.gov/pubmed/36699199
http://dx.doi.org/10.2147/PROM.S369584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869695/
https://www.ncbi.nlm.nih.gov/pubmed/36699199
http://dx.doi.org/10.2147/PROM.S369584

Ejemplares similares